Advances in Atypical Antipsychotics for the Treatment of Schizophrenia: New Formulations and New Agents

Author： Kelleher J.P.   Centorrino F.   Albert M.J.   Baldessarini R.J.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.16, Iss.4, 2002-01, pp. : 249-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment-resistant schizophrenia: clinical experience with new antipsychotics

By Dufour H.   Bondolfi G.   Baumann P.   Seywert F.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 202-202

Elsevier

Access to resources Recommend Favorite

Advantages of atypical antipsychotics in the maintenance treatment of schizophrenia

By Kissling W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 188-188

Elsevier

Access to resources Recommend Favorite

New onset diabetes and atypical antipsychotics

By Liebzeit K.A.   Markowitz J.S.   Caley C.F.  

European Neuropsychopharmacology, Vol. 11, Iss. 1, 2001-02 ,pp. : 25-32

Elsevier

Access to resources Recommend Favorite

A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia

By Bhanji N.H.   Chouinard G.   Margolese H.C.  

European Neuropsychopharmacology, Vol. 14, Iss. 2, 2004-03 ,pp. : 87-92

Elsevier

Access to resources Recommend Favorite

Recent advances in novel atypical antipsychotic agents: potential therapeutic agents for the treatment of schizophrenia

By Nakazato A.   Okuyama S.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 1, 2000-01 ,pp. : 75-98

Informa Healthcare

Access to resources Recommend Favorite